Conclusions: There are common pathways, containing differentially methylated genes, in ALD and MASLD, such as pathways in cancer and peroxisome proliferator-activated receptor (PPAR) signaling pathways. Here, PPARA is linked to metabolic dysfunction-associated steatotic liver disease.